Published in Nucl Med Mol Imaging on November 28, 2016
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med (2011) 3.38
Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 3.25
Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies. Br J Radiol (2002) 2.66
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med (2004) 2.55
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol (2008) 2.29
American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant (2006) 2.11
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol (2005) 1.99
Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med (2011) 1.80
Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation (1972) 1.80
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia (2005) 1.78
Cancer incidence and risk factors after solid organ transplantation. Int J Cancer (2009) 1.78
Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol (2005) 1.75
PET/CT today and tomorrow. J Nucl Med (2004) 1.68
18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging (2008) 1.52
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol (2013) 1.50
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med (2013) 1.37
PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol (2009) 1.33
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol (2010) 1.22
Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18
Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int (2007) 1.14
F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med (2009) 1.12
High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant (2006) 1.10
Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review. J Comput Assist Tomogr (2011) 1.10
Complications of percutaneous liver biopsy in children. Gastroenterology (1992) 1.03
Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol (2007) 1.03
A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. Eur J Radiol (2010) 1.00
Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. J Nucl Med (2001) 0.99
FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics (2005) 0.97
The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med (2007) 0.97
Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract (2008) 0.96
The impact of PET on the management of lung cancer: the referring physician's perspective. J Nucl Med (2002) 0.93
Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med (2001) 0.92
How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant (2006) 0.92
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder. Leuk Lymphoma (2013) 0.90
Complications of prostate biopsy. Expert Rev Anticancer Ther (2013) 0.88
Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities. Eur J Nucl Med Mol Imaging (2014) 0.87
Interventional positron emission tomography/computed tomography: state-of-the-art. Tech Vasc Interv Radiol (2013) 0.86
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Haematologica (2012) 0.85
Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J Clin Pathol (1995) 0.84
2009 global data in organ donation and transplantation: activities, laws, and organization. Transplantation (2011) 0.81
Immunosuppression: practice and trends. Am J Transplant (2003) 0.81
Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement. Q J Nucl Med Mol Imaging (2013) 0.79
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer. Ann Nucl Med (2015) 0.79
Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients. Eur J Nucl Med Mol Imaging (2012) 0.77
Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach. Clin Nucl Med (2015) 0.77
Fluordeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transpl (2006) 0.77
Diagnostic role of whole-body [18F]-FDG positron emission tomography in patients with symptoms suspicious for malignancy after heart transplantation. J Heart Lung Transplant (2012) 0.76
The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients. Hell J Nucl Med (2015) 0.76